Unipath Specialty Laboratory Profile
Key Indicators
- Authorised Capital ₹ 35.76 Cr
as on 16-06-2024
- Paid Up Capital ₹ 22.76 Cr
as on 16-06-2024
- Company Age 15 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 25.00 Cr
as on 16-06-2024
- Satisfied Charges ₹ 14.85 Cr
as on 16-06-2024
- Revenue -15.16%
(FY 2023)
- Profit -157.87%
(FY 2023)
- Ebitda -172.09%
(FY 2023)
- Net Worth -15.17%
(FY 2023)
- Total Assets 7.21%
(FY 2023)
About Unipath Specialty Laboratory
The Corporate was formerly known as Unipath Specialty Laboratory Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 35.76 Cr and a paid-up capital of Rs 22.76 Cr.
The company currently has active open charges totaling ₹25.00 Cr. The company has closed loans amounting to ₹14.85 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Unipath Specialty Laboratory Limited India are Jwalant Shah as CEO and Abhishek Rawka as Cfo. Jwalant Shah, Mahesh Mohatta, Urmish Chudgar, and One other member serve as directors at the Company.
- CIN/LLPIN
U85195GJ2009PLC057059
- Company No.
057059
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
26 May 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Unipath Specialty Laboratory?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jwalant Shah  | CEO | 01-Feb-2017 | Current |
| Abhishek Rawka | CFO | 17-Apr-2023 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prema Iyer | Director | 01-Dec-2022 | Current |
| Mahesh Mohatta | Director | 02-Aug-2011 | Current |
| Jwalant Shah | Whole-Time Director and Ceo | 26-May-2009 | Current |
| Urmish Chudgar | Director | 26-May-2009 | Current |
Financial Performance of Unipath Specialty Laboratory.
Unipath Specialty Laboratory Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 15.16% decrease. The company also saw a substantial fall in profitability, with a 157.87% decrease in profit. The company's net worth observed a substantial decline by a decrease of 15.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Unipath Specialty Laboratory?
In 2023, Unipath Specialty Laboratory had a promoter holding of 100.00%. The company had 12 Subsidiaries, 1 Joint Venture and 4 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Advanced Transfusion Medicine Research FoundationActive 27 years 8 monthsJwalant Shah, Mahesh Mohatta and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 21 Jul 2022 | ₹19.00 Cr | Open |
Others Creation Date: 13 Jul 2019 | ₹2.00 Cr | Open |
Hdfc Bank Limited Creation Date: 21 Jun 2017 | ₹4.00 Cr | Open |
How Many Employees Work at Unipath Specialty Laboratory?
Unipath Specialty Laboratory has a workforce of 1031 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unipath Specialty Laboratory, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unipath Specialty Laboratory's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
